Joutsa, J
Voon, V
Johansson, J
Niemelä, S
Bergman, J
Kaasinen, V
Article History
Received: 5 July 2014
Revised: 25 October 2014
Accepted: 18 November 2014
First Online: 6 January 2015
Competing interests
: J Joutsa has received lecturer honoraria from Boehringer-Ingelheim and a research grant from Lundbeck. VV is a Wellcome Trust Intermediate Clinical Fellow (093705/Z/10/Z). SN has received lecture fees from Janssen-Cilag, Lundbeck, Orion-Pharma and Sanofi-Aventis, a travel grant from Lundbeck, and served as a member of advisory board of Lundbeck. VK has received speaker honoraria and/or travel grants from Merck, Medtronic, Orion-Pharma, Abbvie, UCB and Lundbeck; and has served as a member of the advisory board of UCB and as a consultant for Orion-Pharma and Lundbeck. The remaining authors declare no conflict of interest.